Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8719896 | The Journal of Emergency Medicine | 2017 | 4 Pages |
Abstract
Although therapeutically dosed scopolamine transdermal patches rarely cause complications, incomplete toxidromes can be insidiously common in polypharmacy settings. Providers should thoroughly evaluate the skin of intoxicated patients for additional adherent medications that may result in a delay in ED diagnosis and curative therapies. Our case, as well as rare case reports of therapeutic scopolamine-induced anticholinergic toxicity, demonstrates that peripheral anticholinergic effects, such as tachycardia, dry mucous membranes, and hyperpyrexia are often not present, and incremental doses of physostigmine may be required to reverse scopolamine's long duration of action. This further complicates identification of the anticholinergic toxidrome and diagnosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Xiao Chi MD, MS, Natalija PharmD, BCPS, DABAT, Thomas MD, Jason MD,